Michael T. Andriole - Feb 1, 2024 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 06:16 PM
Previous filing
Dec 29, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $0 +83.8K +22.94% $0.00 449K Feb 1, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +503K $0.00 503K Feb 1, 2024 Common Stock 503K $0.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 20,937 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 20,937 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 20,937 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 20,939 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.